Zai Lab Ltd ZLAB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:26 PM EDT
18.61quote price arrow down-1.55 (-7.69%)
Volume
187,817
52 week range
13.48 - 37.92
Loading...
  • Open19.42
  • Day High19.48
  • Day Low18.60
  • Prev Close20.16
  • 52 Week High37.92
  • 52 Week High Date06/02/23
  • 52 Week Low13.48
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap1.846B
  • Shares Out99.21M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-30.7

KEY STATS

  • Open19.42
  • Day High19.48
  • Day Low18.60
  • Prev Close20.16
  • 52 Week High37.92
  • 52 Week High Date06/02/23
  • 52 Week Low13.48
  • 52 Week Low Date04/18/24
  • Market Cap1.846B
  • Shares Out99.21M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-30.7

RATIOS/PROFITABILITY

  • EPS (TTM)-3.50
  • P/E (TTM)-5.32
  • Fwd P/E (NTM)-5.75
  • EBITDA (TTM)-367.977M
  • ROE (TTM)-38.44%
  • Revenue (TTM)291.071M
  • Gross Margin (TTM)62.86%
  • Net Margin (TTM)-116.45%
  • Debt To Equity (MRQ)6.33%

EVENTS

  • Earnings Date08/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zai Lab Ltd

 

Profile

MORE
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib...
Du Ying Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Joshua Smiley
President, Chief Operating Officer
Yajing Chen
Chief Financial Officer
Address
4560 Jinke Road, Bldg. 1, 4/F, Pudong
Shanghai, SHA
201210
China

Top Peers

SYMBOLLASTCHG%CHG
PTGX
Protagonist Therapeutics Inc
31.51-0.20-0.63%
ADMA
ADMA Biologics Inc
9.57-0.06-0.57%
MRVI
Maravai LifeSciences Holdings Inc
10.98-0.07-0.59%
BEAM
Beam Therapeutics Inc
24.64-0.24-0.96%
KNSA
Kiniksa Pharmaceuticals Ltd
19.39+0.12+0.62%